chr6-80229511-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001424035.1(BCKDHB):​c.951+26299G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.313 in 152,018 control chromosomes in the GnomAD database, including 7,934 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7934 hom., cov: 32)

Consequence

BCKDHB
NM_001424035.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.204

Publications

7 publications found
Variant links:
Genes affected
BCKDHB (HGNC:987): (branched chain keto acid dehydrogenase E1 subunit beta) This gene encodes the E1 beta subunit of branched-chain keto acid dehydrogenase, which is a multienzyme complex associated with the inner membrane of mitochondria. This enzyme complex functions in the catabolism of branched-chain amino acids. Mutations in this gene have been associated with maple syrup urine disease (MSUD), type 1B, a disease characterized by a maple syrup odor to the urine in addition to mental and physical retardation and feeding problems. Alternative splicing at this locus results in multiple transcript variants. [provided by RefSeq, Jan 2016]
BCKDHB Gene-Disease associations (from GenCC):
  • maple syrup urine disease type 1B
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
  • maple syrup urine disease
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001424035.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHB
NM_183050.4
MANE Select
c.951+26299G>A
intron
N/ANP_898871.1
BCKDHB
NM_001424035.1
c.951+26299G>A
intron
N/ANP_001410964.1
BCKDHB
NM_000056.5
c.951+26299G>A
intron
N/ANP_000047.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHB
ENST00000320393.9
TSL:1 MANE Select
c.951+26299G>A
intron
N/AENSP00000318351.5
BCKDHB
ENST00000356489.9
TSL:1
c.951+26299G>A
intron
N/AENSP00000348880.5
BCKDHB
ENST00000929318.1
c.951+26299G>A
intron
N/AENSP00000599377.1

Frequencies

GnomAD3 genomes
AF:
0.313
AC:
47510
AN:
151900
Hom.:
7937
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.326
Gnomad EAS
AF:
0.304
Gnomad SAS
AF:
0.229
Gnomad FIN
AF:
0.381
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.385
Gnomad OTH
AF:
0.314
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.313
AC:
47508
AN:
152018
Hom.:
7934
Cov.:
32
AF XY:
0.310
AC XY:
23067
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.198
AC:
8191
AN:
41466
American (AMR)
AF:
0.276
AC:
4220
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.326
AC:
1131
AN:
3466
East Asian (EAS)
AF:
0.305
AC:
1576
AN:
5174
South Asian (SAS)
AF:
0.229
AC:
1103
AN:
4822
European-Finnish (FIN)
AF:
0.381
AC:
4019
AN:
10538
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.385
AC:
26191
AN:
67946
Other (OTH)
AF:
0.312
AC:
659
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1639
3279
4918
6558
8197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.356
Hom.:
12978
Bravo
AF:
0.306
Asia WGS
AF:
0.238
AC:
825
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.1
DANN
Benign
0.52
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs688867; hg19: chr6-80939228; COSMIC: COSV57517835; API